+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Glucose Monitoring Devices. Measuring Blood Glucose to Manage and Control Diabetes

  • Book

  • June 2020
  • Elsevier Science and Technology
  • ID: 4772193

Glucose Monitoring Devices: Measuring Blood Glucose to Manage and Control Diabetes presents the state-of-the-art regarding glucose monitoring devices and the clinical use of monitoring data for the improvement of diabetes management and control. Chapters cover the two most common approaches to glucose monitoring-self-monitoring blood glucose and continuous glucose monitoring-discussing their components, accuracy, the impact of use on quality of glycemic control as documented by landmark clinical trials, and mathematical approaches. Other sections cover how data obtained from these monitoring devices is deployed within diabetes management systems and new approaches to glucose monitoring.

This book provides a comprehensive treatment on glucose monitoring devices not otherwise found in a single manuscript. Its comprehensive variety of topics makes it an excellent reference book for doctoral and postdoctoral students working in the field of diabetes technology, both in academia and industry.

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Table of Contents

SECTION 1: SELF-MONITORING BLOOD GLUCOSE DEVICES 1. Introduction to SMBG 2. Analytical performance of SMBG systems 3. Clinical evaluation of SMBG systems 4. Consequences of SMBG systems inaccuracy 5. Modeling the SMBG measurement error

SECTION 2: CONTINUOUS GLUCOSE MONITORING DEVICES 6. CGM sensor technology 7. Clinical impact of CGM use 8. Accuracy of CGM systems 9. Calibration of CGM systems 10. CGM filtering and denoising techniques 11. Retrofitting CGM traces 12. Modeling the CGM measurement error

SECTION 3: CLINICAL USE OF MONITORING DATA 13. Low-glucose suspend systems 14. Predictive low-glucose suspend systems 15. Automated closed-loop insulin delivery: system components, performance, and limitations 16. The dawn of automated insulin delivery: from promise to product

Authors

Chiara Fabris Center for Diabetes Technology, Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, USA. Dr. Chiara Fabris is Assistant Professor at the University of Virginia School of Medicine and member of the faculty at the Center for Diabetes Technology. She holds a Master's and a Doctoral Degree in Bioengineering from the University of Padova (Padova, Italy) and has significant experience in mathematical modeling and simulation - especially regarding the glucose/insulin regulation system - and algorithm development. Over the past four years, Dr. Fabris has been awarded an Advanced Postdoctoral Fellowship and a Career Development Award by the Juvenile Diabetes Research Foundation, which supported the development and clinical testing of decision support systems to help people with diabetes manage their disease. Dr. Fabris is involved in several projects focused on optimization of treatments for diabetes and diabetes data science. Boris Kovatchev Center for Diabetes Technology, Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, USA. Dr. Boris Kovatchev is Professor at the University of Virginia School of Medicine and School of Engineering, and founding director of the Center for Diabetes Technology. He has a 30-year track record in mathematical modeling, biosimulation, and algorithm development. Currently, he is Principal Investigator of several projects dedicated to Diabetes Data Science and the development of artificial pancreas and decision support systems, including the large-scale NIH International Diabetes Closed-Loop Trial and the UVA Strategic Investment Fund project "Precision Individualized Medicine for Diabetes�. Dr. Kovatchev is author of over 200 peer-reviewed publications and holds 85 patents.